Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Basal Insulin Oct 24 | 2019Biocon CY Q3 ’19 (FY Q2 ’20) Earnings UpdatePurchase Blast
$599
Posted in: Dual/triple agonist, SGLT2i Oct 24 | 2019AstraZeneca Q3 '19 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucagon, SGLT2i Oct 23 | 2019Lilly Q3 '19 Earnings Update; Conterno to RetirePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Oct 23 | 2019Thoughts on Medtronic Diabetes Leadership ChangePurchase Blast
$599
Posted in: Bolus Insulin, Insulin Delivery Oct 23 | 2019Fiasp Approved for Pump Use in USPurchase Blast
$599
Posted in: Glucose Monitoring, Other Oct 16 | 2019Abbott Acknowledges Libre 2 Delay; Abbott and Roche Q3 '19 Earnings UpdatesPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 15 | 2019Abbott and Tandem partnership; Livongo partners with VSP Vision CarePurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Other Oct 14 | 2019Abbott Partners with Omada; New Senseonics BCBS Coverage; Adocia Receives €15M in Funding; Roche Partners with iHeartMediaPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, SGLT2i Oct 14 | 2019Lilly Nasal Glucagon CHMP Opinion This Week (CHMP Agenda October 14-17)Purchase Blast
$599
Posted in: Glucose Monitoring Oct 14 | 2019Abbott Libre 2 US Approval Conspicuously Late?Purchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring Oct 08 | 2019Intarcia Re-files ITCA-650; New Dexcom G6 Professional CGM; One Drop/Walmart PartnershipPurchase Blast
$599
Posted in: Insulin Delivery Oct 04 | 2019New Medtronic Extended Wear Infusion Set TrialPurchase Blast
$599
Posted in: Basal Insulin Oct 02 | 2019Mylan Faces Setback in Sanofi Bs-Glargine LawsuitPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucose Monitoring, Insulin Delivery, Other Oct 01 | 2019Sanofi to Unveil New Strategy in December; Novo Obesity Partnership; Lifescan to Expand BGM AccessPurchase Blast
$599
Posted in: Glucose Monitoring Sep 30 | 2019Senseonics Completes Enrollment for 180-Day CGM TrialPurchase Blast
$599
Posted in: SGLT2i Sep 30 | 2019CREDENCE Label Update for Invokana is a Big Win for JanssenPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
